1
Life Science Investment OrganisationDr Hakim YadiNovember 30th 2012                                       2
Who are UKTI?• Team that covers:    – Trade (UK-based companies selling overseas)    – Investment (Foreign Owned Companies...
Who are UKTI?• When working on new investment, we cover:     – Politics, policy and barriers to growth     – Access to Min...
How Do We PromoteInvestment Into The UK?                          5
UK Inward Investment Network: Our Overseas Network                                                                        ...
Source Markets For Inbound FDI 2007-2011Source: fDi Markets, a service from the Financial Times September 2012, Microsoft ...
Sector TrendsUK Inward Investment: Life Sciences            800                                      Forecast            7...
Using the UK Life Science Strategyto support international UK Offers                                     9
A sector under pressure                          10
Why invest in UK Life Sciences?The UK Life Science Strategy – aresponse to a challenged sector.The Life Sciences Strategy ...
We have the know-how• 4 of the world’s top 10 universities• Leading country in the G8 for research productivity• The UK ac...
Life Science Investment Organisation• UKTI has established a new initiative – the  Life Science Investment Organisation (L...
LSIO Targeted Business Development• Plans based on areas of differentiation for the UK Life Science base:    − Dementia Ne...
Delivering the Targeted business development campaign• Step 1: Define UK offer and create top line messages. Based on:    ...
Creating a community Promotion of the UK Life Science strategy  will not happen fast enough or reach the  audience we hop...
How can we help                  17
Working in partnership• UKTI combines the expertise of professional trade and industry advisers in the  UK alongside a glo...
Working in partnership• UKTI has established a dedicated unit focused on UK life sciences. The UKTI  Life Science Investme...
20
Upcoming SlideShare
Loading in …5
×

UKTI

1,038 views

Published on

Presentation given to VINNOVA visit, November 2012

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,038
On SlideShare
0
From Embeds
0
Number of Embeds
195
Actions
Shares
0
Downloads
6
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

UKTI

  1. 1. 1
  2. 2. Life Science Investment OrganisationDr Hakim YadiNovember 30th 2012 2
  3. 3. Who are UKTI?• Team that covers: – Trade (UK-based companies selling overseas) – Investment (Foreign Owned Companies investing in the UK) 3
  4. 4. Who are UKTI?• When working on new investment, we cover: – Politics, policy and barriers to growth – Access to Ministers – Campaigns – R&D collaborations – Project management of new investment projects• We are organised sectorally, including Life Science and Health – Backed up by sector experts in sub segments – Within this there is currently a special focus on life science and health: the Life Sciences Investment Organisation (LSIO) November 07, 2012 4
  5. 5. How Do We PromoteInvestment Into The UK? 5
  6. 6. UK Inward Investment Network: Our Overseas Network 232 FTE (FDI) 3 Regional Hubs (Hong Kong, New York & Paris)Source: Great Britain & Northern Ireland – UK Inward Investment Network, Our Team, July 2012 6
  7. 7. Source Markets For Inbound FDI 2007-2011Source: fDi Markets, a service from the Financial Times September 2012, Microsoft Map Point 7
  8. 8. Sector TrendsUK Inward Investment: Life Sciences 800 Forecast 700 Life Sciences 600 500 Projects 400 300 200 100 0 8
  9. 9. Using the UK Life Science Strategyto support international UK Offers 9
  10. 10. A sector under pressure 10
  11. 11. Why invest in UK Life Sciences?The UK Life Science Strategy – aresponse to a challenged sector.The Life Sciences Strategy is the UK’sresponse to a global problem of risingcosts and complexity of research anddevelopment, and the need forproducts and services to addresspatients needs and the needs of anageing population. 11
  12. 12. We have the know-how• 4 of the world’s top 10 universities• Leading country in the G8 for research productivity• The UK accounts for 6% of world publications and a global share of 14% of the most-cited papers• Scientists in the UK have been awarded more than 76 Nobel Prizes (35 and counting for medical research)• The UK has a rich heritage in transformative science with a proven track record in drug discovery – more than 20% of biopharmaceuticals in development originated in the UK 12
  13. 13. Life Science Investment Organisation• UKTI has established a new initiative – the Life Science Investment Organisation (LSIO)• The LSIO is charged with: – Creating a clearer presentation of the UK’s capabilities and offering to the Global Life Sciences sector – Targeted business development based on UK strengths and global market needs – Creating and empowering a community of UK Life Science ambassadors 13
  14. 14. LSIO Targeted Business Development• Plans based on areas of differentiation for the UK Life Science base: − Dementia Neurology − Stratified Medicine − Experimental Medicine − Medical Technologies and convergence• UKTI will target both existing Life Science companies (e.g. Pharma) and disruptive companies (e.g. telehealth/eHealth) that would benefit from working with the UK• In addition, UKTI will work with the investment community to understand how the UK’s science offering can generate new investment-fund related opportunities• The business plan will be continuously refreshed and updated on a monthly cycle 14
  15. 15. Delivering the Targeted business development campaign• Step 1: Define UK offer and create top line messages. Based on: − Basic and applied research, Academic-clinical partnerships with industry, Patient stratification and NHS access, SMEs and industry sectors − Step 2: Create selling and delivery toolkit − Step 3: Identify companies and individuals to target with the proposition − Step 4: Engage companies, present the proposition and follow through on investment opportunities − Step 5: Report back to stakeholders on any gaps in the proposition to ensure the UK Life Science Strategy is in tune with industry needs 15
  16. 16. Creating a community Promotion of the UK Life Science strategy will not happen fast enough or reach the audience we hope to through UKTI alone Global Life Sciences UKTI have identified a community that can benefit from being part of an extended virtual team, these individuals will be approached to help promote the unified proposition We need to change the misconceptions of the sector and promote positive messages of UK success 16
  17. 17. How can we help 17
  18. 18. Working in partnership• UKTI combines the expertise of professional trade and industry advisers in the UK alongside a global network of experts based in British diplomatic offices overseas, giving you access to a well-connected presence on the ground at home and in the UK.• Our practical help and advice for inward investment is free and confidential. We work closely with other government departments and the wider UK Life Science community to provide excellent service and present the best UK offer.• Your business’ journey is important to us, from when your business is first considering making an investment in the UK to once it is well established – we are here to support your business’ ongoing and future activities 18
  19. 19. Working in partnership• UKTI has established a dedicated unit focused on UK life sciences. The UKTI Life Science Investment Organisation (LSIO) is your partner acting as a simple interface to the UK Life Science sector.• The LSIO is your guide to identifying research, development and delivery partners and will support you through every step of investing in and working in the UK.• “UKTI connects your business to subject matter and experts across the Life Sciences and healthcare sector in the UK.” 19
  20. 20. 20

×